Kostić, E.; Dimitrijević, Z.; Apostolović, B.; Paunović, K.; Mitić, B.
Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study. J. Clin. Med. 2025, 14, 7905.
https://doi.org/10.3390/jcm14227905
AMA Style
Kostić E, Dimitrijević Z, Apostolović B, Paunović K, Mitić B.
Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study. Journal of Clinical Medicine. 2025; 14(22):7905.
https://doi.org/10.3390/jcm14227905
Chicago/Turabian Style
Kostić, Emina, Zorica Dimitrijević, Branislav Apostolović, Karolina Paunović, and Branka Mitić.
2025. "Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study" Journal of Clinical Medicine 14, no. 22: 7905.
https://doi.org/10.3390/jcm14227905
APA Style
Kostić, E., Dimitrijević, Z., Apostolović, B., Paunović, K., & Mitić, B.
(2025). Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study. Journal of Clinical Medicine, 14(22), 7905.
https://doi.org/10.3390/jcm14227905